Print Page     Close Window     

SEC Filings

8-K
SERES THERAPEUTICS, INC. filed this Form 8-K on 03/06/2019
Entire Document
 


Item 2.02. Results of Operations and Financial Condition.

On March 6, 2019, Seres Therapeutics, Inc. (the “Company”) announced its financial results for the year and quarter ended December 31, 2018 and provided operational updates. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

 

  (d)

Exhibit

The following exhibit relates to Item 2.02, which shall be deemed to be furnished, and not filed:

 

Exhibit
No.

  

Description

99.1    Press Release issued on March 6, 2019

© Seres Therapeutics. All Rights Reserved.